All In Biotech

Free tool

FAERS Monitor: Tyrvaya

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 19, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 213978 or its brand name (Tyrvaya, Varenicline Tartrate). Reports on generic versions are filed under their own applications.

Reports

6,231

Serious

1,606

26% of reports

Hospitalization

519

Death reported

71

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • sneezing749
  • nausea586
  • drug ineffective473
  • vomiting398
  • depression364
  • headache311
  • nasal discomfort263
  • product delivery mechanism issue252
  • rhinorrhoea236
  • suicidal ideation225
  • nightmare213
  • abnormal dreams212
  • cough207
  • eye pain200
  • insomnia199

Reports by year received

View as table
YearReports
200768
2008839
2009478
2010187
201145
201266
201331
201433
201553
201640
201745
201851
201965
202054
202153
2022654
2023806
20241,555
2025649
2026459

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,047,928 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
product delivery mechanism issueSignal252165.9146.639,231
sneezingSignal749116.6108.982,935
nasal discomfortSignal263115.8102.728,835
abnormal dreamsSignal21226.122.95,062
nightmareSignal21320.918.33,998
rhinorrhoeaSignal23612.410.92,452
eye painSignal20012.010.52,005
suicidal ideationSignal2258.37.31,443
depressionSignal3645.44.91,315
vomitingSignal3982.92.6490
insomniaSignal1992.52.2184
nauseaSignal5862.52.3546
coughSignal2072.52.2186
headache3111.71.586
drug ineffective4731.21.118

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.